Search Results - "Naesdal, J"

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom‐specific anxiety scale by Labus, J. S., Bolus, R., Chang, L., Wiklund, I., Naesdal, J., Mayer, E. A., Naliboff, B. D.

“…Summary Background : Anxiety related to gastrointestinal sensations, symptoms or the contexts in which these may occur is thought to play a significant role in…”
Get full text

Systematic review: ulcer definition in NSAID ulcer prevention trials by YEOMANS, N. D., NÆSDAL, J.

“…Summary Background  In clinical trials of peptic ulcer prevention, the most appropriate definition of an ulcer remains challenging. Aims  To evaluate the ulcer…”
Get full text

Randomized, double‐blind, placebo‐controlled trial of prednisolone in post‐infectious irritable bowel syndrome by Dunlop, S. P., Jenkins, D., Neal, K. R., Naesdal, J., Borgaonker, M., Collins, S. M., Spiller, R. C.

“…Summary Background : Post‐infectious irritable bowel syndrome is associated with increased serotonin‐containing enterochromaffin cells and lymphocytes in…”
Get full text

Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors by SCHEIMAN, James M, YEOMANS, Neville D, AHLBOM, Henrik, NAESDAL, Jørgen, HAWKEY, Christopher, TALLEY, Nicholas J, VAKIL, Nimish, CHAN, Francis K. L, TULASSAY, Zsolt, RAINOLDI, Jorge L, SZCZEPANSKI, Leszek, UNG, Kjell-Arne, KLECZKOWSKI, Dariusz

“…Proton pump inhibitors reduce ulcer recurrence in non-steroidal anti-inflammatory drug (NSAID) users, but their impact in at-risk ulcer-free patients using the…”
Get full text

Predictors of gastroduodenal erosions in patients taking low‐dose aspirin by HART, J., HAWKEY, C. J., LANAS, A., NAESDAL, J., TALLEY, N. J., THOMSON, A. B. R., YEOMANS, N. D.

“…Summary Background  Gastroduodenal ulcers are common in patients taking low‐dose aspirin. However, the factors predisposing to mucosal erosions, the precursor…”
Get full text

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin by YEOMANS, N. D., LANAS, A. I., TALLEY, N. J., THOMSON, A. B. R., DANESHJOO, R., ERIKSSON, B., APPELMAN‐ESZCZUK, S., LÅNGSTRÖM, G., NAESDAL, J., SERRANO, P., SINGH, M., SKELLY, M. M., HAWKEY, C. J.

“…Summary Background : Aspirin is valuable for preventing vascular events, but information about ulcer frequency is necessary to inform risk‐benefit decisions in…”
Get full text

An Irritable Bowel Syndrome-Specific Symptom Questionnaire: Development and Validation by WIKLUND, I. K, FULLERTON, S, HAWKEY, C. J, JONES, R. H, LONGSTRETH, G. F, MAYER, E. A, PEACOCK, R. A, WILSON, I. K, NAESDAL, J

“…Background: No self-assessment instruments are available to assess symptoms of irritable bowel syndrome (IBS). Our aim was to develop a disease-specific…”
Get full text

Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers by Niazi, M, Andersson, T, Nauclér, E, Sundin, M, Naesdal, J

“…To evaluate the effect of esomeprazole on the pharmacokinetics of low-dose acetylsalicylic acid (ASA) during repeated co-administration. This was an open,…”
Get full text

Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non‐steroidal anti‐inflammatory drugs by HAWKEY, C. J., JONES, R. H., YEOMANS, N. D., SCHEIMAN, J. M., TALLEY, N. J., GOLDSTEIN, J. L., AHLBOM, H., NÆSDAL, J.

“…Summary Background The use of non‐steroidal anti‐inflammatory drugs (NSAIDs) is often associated with upper gastrointestinal symptoms such as heartburn and…”
Get full text

Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use? by Yeomans, N D, Svedberg, L-E, Naesdal, J

“…Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of serious gastroduodenal events. To minimise these risks, patients often…”
Get more information

Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials by Longstreth, G. F., Hawkey, C. J., Mayer, E. A., Jones, R. H., Naesdal, J., Wilson, I. K., Peacock, R. A., Wiklund, I. K.

“…Background: Variation in the characteristics of irritable bowel syndrome patients recruited for clinical trials from different sources could affect their…”
Get full text

Impact of irritable bowel syndrome on patientsʼ lives: development and psychometric documentation of a disease-specific measure for use in clinical trials by Longstreth, George F, Bolus, Roger, Naliboff, Bruce, Chang, Lin, Kulich, Károly R, Carlsson, Jonas, Mayer, Emeran A, Naesdal, Jörgen, Wiklund, Ingela K

“…OBJECTIVETo develop a disease-specific questionnaire to capture the impact of irritable bowel syndrome (IBS) and its treatment on patientsʼ lives, the…”
Get full text

A double‐blind placebo‐controlled study of buspirone‐stimulated prolactin release in non‐ulcer dyspepsia—are central serotoninergic responses enhanced? by Dinan, T. G., Mahmud, N., Rathore, O., Thakore, J., Scott, L. V., Carr, E., Naesdal, J., O'Morain, C. A., Keeling, P. W. N.

“…Background: Dyspepsia is a common symptom for which an organic cause is found in only 40% of patients. When no cause is apparent and the dyspepsia is…”
Get full text

Esomeprazole reduces gastric and duodenal ulcer development among high risk NSAID users by Scheiman, J. M., Yeomans, N., Hawkey, C. J., Talley, N. J., Gothe, L., Sung, J., Jones, R., Naesdal, J.

Get full text

Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis by Eriksson, S, Långström, G, Rikner, L, Carlsson, R, Naesdal, J

“…This paper is a meta-analysis of 30 published, double-blind clinical trials comparing omeprazole with ranitidine or cimetidine for the treatment of duodenal…”
Get more information

Lack of Pharmacokinetic Interaction between Esomeprazole and the Nonsteroidal Anti-Inflammatory Drugs Naproxen and Rofecoxib in Healthy Subjects by Hassan-Alin, M, Naesdal, J, Nilsson-Pieschl, C, Långström, G, Andersson, T

“…We investigated the potential interactions between esomeprazole and a non-selective nonsteroidal anti-inflammatory drug (NSAID; naproxen) or a cyclo-oxygenase…”
Get full text

Evaluation of bioequivalence between a single-capsule formulation of esomeprazole 40 mg and acetylsalicylic acid 325 mg and the monotherapies given separately in healthy volunteers by Niazi, M, Andersson, T, Nauclér, E, Næsdal, J

“…The aim of this study was to investigate the bioequivalence of a single oral dose of esomeprazole 40 mg and acetylsalicylic acid 325 mg when formulated as a…”
Get full text

Selective 5-lipoxygenase inhibition in ulcerative colitis by Laursen, L S, Naesdal, J, Bukhave, K, Lauritsen, K, Rask-Madsen, J

“…Leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) concentrations were measured in rectal dialysis fluid from ten patients with active ulcerative colitis before…”
Get more information

Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole by ANDERSSON, T, BREDBERG, E, LAGERSTRÖM, P.-O, NAESDAL, J, WILSON, I

“…To study, in three separate investigations, the potential interaction between omeprazole and three different non-steroidal anti-inflammatory drugs (NSAIDs;…”
Get full text

Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol by Yeomans, Ingalill Wilson, Göran Längström, Christopher Hawkey, Jörgen Naesdal, Anders Walan, Ingela Wiklund, Neville

“…Objective : To compare the impact on quality of life (QoL) of omeprazole and misoprostol during healing, and omeprazole, misoprostol, and placebo during…”
Get full text